Diabetic peripheral neuropathy is one of the most common complications of diabetes, potentially leading to loss of sensation, foot ulcerations and eventually amputation¹.
Treatment of these complications can be expensive² yet many are avoidable³, making early identification and intervention key to improving patient outcomes and reducing health costs.
Neuropen® is the only peripheral neuropathy screening device incorporating both pressure and sharpness tests, giving clinicians a simple, compact solution for testing
large and small nerve fibres in the foot.
Peripheral neuropathy cannot be excluded without regular foot screening in conjunction with symptomatic and clinical assessments.
Neuropen®is an effective aid to this screening programme, meeting and exceeding current practices by being the first dual-purpose, pocket-sized device designed to provide a safe and reliable test.
